These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2619427)

  • 1. Pharmacokinetics of dipyridamole-beta-cyclodextrin complex in dogs.
    Stracciari GL; Malvisi J; Anfossi P; Fregnan GB
    Arch Int Pharmacodyn Ther; 1989; 300():7-13. PubMed ID: 2619427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of dipyridamole-beta-cyclodextrin complex in healthy volunteers after single and multiple doses.
    Ricevuti G; Mazzone A; Pasotti D; Uccelli E; Pasquali F; Gazzani G; Fregnan GB
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):197-201. PubMed ID: 1814737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of specific biological activity of dipyridamole by complexation with beta-cyclodextrin.
    Fregnan GB; Bertè F
    Pharmacology; 1990; 40(2):96-102. PubMed ID: 2345776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
    Cadel S; Bongrani S
    Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M; Haragh L; Pintye-Hódi K
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
    Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
    Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations.
    Uekama K; Arimori K; Sakai A; Masaki K; Irie T; Otagiri M
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2910-3. PubMed ID: 3677241
    [No Abstract]   [Full Text] [Related]  

  • 9. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
    Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
    Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.
    Gerlóczy A; Fónagy A; Keresztes P; Perlaky L; Szejtli J
    Arzneimittelforschung; 1985; 35(7):1042-7. PubMed ID: 4052138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets.
    Fridriksdóttir H; Loftsson T; Gudmundsson JA; Bjarnason GJ; Kjeld M; Thorsteinsson T
    Pharmazie; 1996 Jan; 51(1):39-42. PubMed ID: 8999433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a phenytoin beta-cyclodextrin complex and evaluation of a suspension and a tablet dosage form prepared from the complex.
    Hegde RP; Rhodes CT
    Pharm Acta Helv; 1985; 60(2):53-7. PubMed ID: 3991746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Application of beta-cyclodextrin during direct pressing of tablets].
    Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B
    Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of hydroxypropyl-beta-cyclodextrin in plasma and urine by size-exclusion chromatography with post-column complexation.
    Szathmary SC
    J Chromatogr; 1989 Jan; 487(1):99-105. PubMed ID: 2715279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
    Jain AC; Aungst BJ; Adeyeye MC
    J Pharm Sci; 2002 Jul; 91(7):1659-68. PubMed ID: 12115827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
    Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
    De Bie AT; Van Ommen B; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of phenindione-beta-cyclodextrin inclusion complex.
    Tous SS; el-Sayed AM; el-Harras SA; Jun HW
    Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent.
    Tokumura T; Tsushima Y; Kayano M; Machida Y; Nagai T
    J Pharm Sci; 1985 Apr; 74(4):496-7. PubMed ID: 3999017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.